Logo
NAD+ 1000mg Vitamin B3 derivative (30ml)

NAD+ 1000mg Vitamin B3 derivative (30ml)

NAD+

Vitamins
  • Distributed by Teleta Pharma Ltd, an MHRA Accredited, WDA Certified and GDP Compliant pharmaceutical wholesaler.
  • Product supplied through professional prescription channels in line with UK medicines supply regulations.
Vitamin Injections

Description

NAD+ 1000mg Vitamin B3 derivative (30ml) is a clinical-grade Nicotinamide Adenine Dinucleotide (NAD+) injectable supplement for professional use, supplied in a 30ml vial containing 1000mg of high-purity NAD+. It is designed for administration via intravenous infusion or subcutaneous injection, with flexible dosing that can be tailored by healthcare professionals to individual patient needs. NAD+ is a vitamin B3-derived coenzyme involved in cellular energy production, DNA repair, neuroprotection, metabolic regulation and healthy ageing. Endogenous NAD+ levels naturally decline with age, and supplementation may help support optimal cellular function, recovery, cognitive performance and overall vitality. This product is supplied as a cold-chain item and must be stored refrigerated between 2–8°C.

Bnefits

  • Provides 1000mg of high-purity NAD+ in a 30ml vial for professional use.
  • Supports cellular energy production (ATP synthesis) through its role as a key coenzyme.
  • Supports DNA repair and cellular defence mechanisms.
  • Supports neuroprotection and cognitive function.
  • Supports metabolic regulation and healthy ageing processes.
  • Flexible dosing allows individualisation of treatment by a healthcare professional.
  • Injectable formulation suitable for intravenous infusion or subcutaneous injection.
  • Cold-chain product supplied by an MHRA-accredited, WDA-certified, GDP-compliant pharmaceutical wholesaler.

Indications

  • For professional use in adults where a qualified healthcare professional has determined that NAD+ supplementation is appropriate.
  • To support cellular energy production and help address fatigue or reduced physical performance, as part of a clinician-supervised protocol.
  • To support cognitive function and neuroprotection within a broader treatment plan determined by a healthcare professional.
  • To support metabolic regulation and healthy ageing where NAD+ optimisation is part of the therapeutic strategy.
  • Use only under the direction and supervision of a suitably qualified prescriber in accordance with local regulations and guidelines.

Composition

  • Nicotinamide Adenine Dinucleotide (NAD+) 1000mg per 30ml vial (vitamin B3 derivative coenzyme).
  • Aqueous injectable solution base (exact excipient composition not specified by the distributor in publicly available information).

Formulation

  • Sterile injectable solution intended for intravenous infusion or subcutaneous injection.
  • High-purity NAD+ (vitamin B3 derivative) in solution for parenteral administration.
  • Professional-use-only formulation supplied via prescription channels.

Packaging

  • 1 x 30ml vial containing a total of 1000mg NAD+.
  • Cold chain product; must be kept refrigerated between 2–8°C during storage and transport.
  • Supplied as part of Teleta Pharma’s NAD+ vitamin injection range.

Usage

  • For professional use only; administration should be performed by a suitably qualified healthcare professional.
  • Route of administration: intravenous infusion or subcutaneous injection, as determined by the prescriber.
  • Dosage and dosing schedule must be individualised by the healthcare professional based on the patient’s health goals, clinical status, concomitant conditions and medications.
  • Ensure the product has been stored within the specified temperature range (2–8°C) and that cold chain has been maintained prior to use.
  • Use in accordance with relevant local regulations, professional guidelines and institutional protocols for parenteral vitamin and coenzyme therapies.
  • Do not use if the vial appears damaged, the solution is discoloured, contains particulate matter, or if there is any doubt about cold-chain integrity.
  • Record batch number and administration details in the patient’s clinical notes as per local pharmacovigilance and documentation requirements.

Contraindications

  • Specific contraindications are not stated in the publicly available product information.
  • Use is not recommended without prior assessment by a qualified healthcare professional.
  • Healthcare professionals should consider standard contraindications to intravenous and subcutaneous therapies (e.g. known hypersensitivity to components, relevant comorbidities) and follow local clinical guidelines.

Adverse Effects

  • No specific adverse effects are listed in the distributor’s publicly available product information.
  • As with other intravenous or subcutaneous injections, potential risks may include local injection-site reactions, infusion-related reactions or hypersensitivity; clinicians should monitor patients appropriately.
  • Healthcare professionals should report suspected adverse reactions via appropriate pharmacovigilance channels and follow local safety reporting requirements.

Storage Conditions

  • Cold chain product.
  • Store refrigerated between 2–8°C.
  • Do not freeze.
  • Maintain cold chain during transport and handling in accordance with GDP (Good Distribution Practice) principles.
  • Keep out of reach of unauthorised personnel and store in accordance with institutional medicine storage policies.

Duration

Not specified by the distributor; treatment duration and frequency should be defined by the prescribing healthcare professional based on individual patient needs and response.

Onset

Not specified in the available product information; any onset and magnitude of effect will depend on individual patient factors and clinical context.

Browse more Vitamins

Top Treatments

Top Cities in the UK